Validating the Agilent 7700x/7800 ICP-MS for the determination of elemental impurities in pharmaceutical ingredients according to draft USP general chapters <232>/<233>

Validating ICP-MS Using USP<232>/<233> for Elemental Impurity Analysis in Pharmaceutical Products Ed McCurdy1, Amir Liba1, Samina Hussain2. 1: Agilent Technologies Inc., Santa Clara, CA, USA. 2: Exova, Santa Fe Springs, CA, USA Winter Conference on Plasma Spectrochemistry, 2012 ThP43 Introduction…

Application Note Pharmaceuticals Validating performance of an Agilent ICP‑MS for USP <232>/<233> & ICH Q3D(R2)/Q2(R1) Reducing the time and expense of ICP-MS method development and system validation for measuring elemental impurities in pharmaceuticals Authors Lindsey Whitecotton, Ed McCurdy, Craig Jones…

Application Note Pharma & Biopharma Analysis of Artificial Tear Eye Drops For Elemental Impurities Using an ICP-MS and USP <232>/<233> and ICH Q3D(R2)/Q2(R1) protocols. Authors Jennifer Sanderson and Lindsey Whitecotton Agilent Technologies, Inc. Introduction As pharmaceutical products are released to…

Inductively Coupled Plasma Mass Spectrometer ICPMS-2040 Application News Analysis of Pharmaceutical Raw Materials Compliant with ICH Q3D Guideline Using ICP-MS with Collision Mode Yujing Jiang User Benefits  The 24 elements identified in the ICH Q3D guideline can be measured…